The invention features methods and reagents for the diagnosis, monitoring,
and treatment of multiple sclerosis. The invention is based in part on
the discovery that Chlamydia is present in patients with multiple
sclerosis, and that anti-chlamydial agents improve or sustain
neurological function in these patients.